Introduction
Haemolysis after prosthetic mitral valve replacement is frequently recognized, but represents a rare complication following mitral valve repair. In this case report, we describe a patient who developed severe mechanical haemolysis 2 month after mitral valve repair.
Case presentation
A 73-year-old man was admitted to our cardiology department with progressively worsening shortness of breath (New York Heart Association-Classification IV) and fatigue 2 months after surgical mitral valve repair for mitral regurgitation (MR). His recovery had been prolonged due to a haemothorax requiring re-thoracotomy in combination with severe enterococcal sepsis treated with Vancomycin for 2 weeks and a right frontal watershed stroke with a residual paresis of the left arm. The patient's medical history was significant for hypertension, atrial fibrillation, and coronary artery disease, for which he had undergone coronary artery bypass graft surgery in the context of mitral valve repair in November 2016.
Learning points
• It is important to include the diagnosis of haemolytic anaemia after mitral valve repair in patients with a history of heart surgery.
• Mechanical haemolysis rarely resolves spontaneously.
• In most valvular cases, patients will have to undergo valve replacement. 
Timeline
Upon arrival, he had pale conjunctivae and a holosystolic 3/6 apical murmur radiating to the axilla. Mild bibasilar crackles were audible, and there were bilateral lower extremity oedema. Blood pressure was 130/80 mmHg, heart rate was 80 beats per minute, temperature was 36. 6 C, and chest X-ray showed a slight pleural effusion of the left lung without infiltrates. The patient's blood test showed haemoglobin and haptoglobin reduced and lactate dehydrogenase increased as hallmarks of an intravascular extracorpuscular anaemia ( Table 1 ). The haemoglobin level was 6.6 g/day (normal range 13.6-17.2 g/dL), haematocrit was 0.20 (normal range 0.39-0.49), and reticulocyte count was elevated. Haptoglobin was reduced to 0.01 g/dL (normal range 0.5-2.4 g/dL), total bilirubin was 1.4 mg/dL (normal range 0.3-1.2 mg/dL) with an indirect hyperbilirubin of 0.4 mg/dL (normal range <0.2 mg/dL), and lactate dehydrogenase level were elevated to 1382 units per litre (normal range 100-247 units per litre). Brain natriuretic peptide levels were increased to 374.2 pg/mL (normal range <100 pg/mL). Creatinine and cardiac enzyme levels were within normal limits. Given that mechanical haemolysis is rarely observed in patients treated with valve repair, it was essential to exclude other potential causes of haemolysis. The most important differential diagnosis was autoimmune haemolytic anaemia with antibodies against erythrocyte structural components. Autoimmune haemolytic anaemia may develop after severe infections or post-surgery. To exclude autoimmune haemolytic anaemia, a coombs test was performed as well as a specific coombs test and cold agglutination, which were negative, thus supporting the diagnosis of surgery related haemolysis.
Transthoracic and transoesophageal echocardiography revealed a high-grade mitral valve regurgitation and mitral valve stenosis II ( Figure   1A , B, Supplementary material online, Videos S1 and S2). Mean pressure gradient was 7 mmHg with an eccentric jet. Pulmonary hypertension and second degree tricuspid valve regurgitation were detected. The patient developed recurrent transfusion-requiring conditions. At four occasions, a total of eight erythrocyte concentrates were transfused. After reaching a satisfactory general state of health, the patient was referred to valve replacement with a 27 mm biological prosthesis (Sorin Pericarbon) and tricuspidal repair with annuloplasty ring implantation (30 mm Contour 3D Medtronic). The histopathological examination revealed a myxoid mitral valve degeneration.
Haemolysis parameters normalized and the clinical status improved quickly. Within 3 months, all parameters were within normal ranges. Upon his most recent follow-up visitation, 9 month after valve replacement, the patient reported a significantly improved exercise capacity. Control echocardiography showed a good result after mitral valve replacement without residual regurgitation ( Figure 1C ).
Discussion
Mitral regurgitation is the second most common valvular heart disease 1 and can be subdivided in a primary, degenerative form and a secondary mitral valve regurgitation due to ischaemia and dilatation. 2, 3 In primary MR, valve repair is the preferred treatment option. 2 Valve repair provides lower impairment of the left ventricular heart function, lower complication rates, and operative mortality, better long-term results and, no need for anticoagulation. 4 The surgical steps include annuloplasty, shortening of tendinous chords in combination with prolapse and leaflet resection. 5, 6 Patients developing haemolysis after mitral valve repair generally present within the first 2-6 months after surgery. 7 Possible mechanisms of haemolysis after valvular repair are fragmentation of the regurgitant jet by a annuloplasty ring dehiscence, collision of the regurgitant jet into the prosthetic ring, and rapid acceleration of a jet through a small para-ring leakage. [8] [9] [10] The regurgitant jet itself perpetuates haemolysis by delaying endothelialization of the valvuloplasty ring, leading to further fragmentation and collision. 7 In approximately 35% Malaise and fatigue following mitral valve repair
